Intestinal transplantation is lifesaving for patients with injury or disease of the intestines, but surgical success is hampered by high rejection rates resulting from an immune attack of the recipient... read more →
SAN FRANCISCO, March 18, 2021 (GLOBE NEWSWIRE) -- Ossium Health, a therapeutics company harnessing the power of stem cell science to improve treatment for patients with blood and immune diseases,... read more →
Kevin Caldwell, Ossium's Co-Founder & CEO, was featured on the latest podcast from Flux. Kevin chats with Flux's Alice Lloyd George about Ossium's mission, the history of bone marrow transplants,... read more →